RATIONALE: Most virus-induced attacks of asthma are caused by rhinoviruses (RVs). OBJECTIVES: To determine whether people with asthma are susceptible to an increased viral load during RV infection. METHODS: Seventy-four children (4-18 yr old) were enrolled; 28 with wheezing, 32 with acute rhinitis, and 14 without respiratory tract symptoms. Nasal washes were evaluated using quantitative polymerase chain reaction for RV to judge viral load along with gene sequencing to identify strains of RV. Soluble intercellular adhesion molecule-1, IFN-λ1, and eosinophil cationic protein in nasal washes, along with blood eosinophil counts and total and allergen-specific IgE in sera, were also evaluated. Similar assessments were done in 24 young adults (16 with asthma, 8 without) who participated in an experimental challenge with RV (serotype 16). MEASUREMENTS AND MAIN RESULTS: Fifty-seven percent of wheezing children and 56% with acute rhinitis had nasal washes testing positive for RV. The geometric mean of viral loads by quantitative polymerase chain reaction in washes from wheezing children was 2.8-fold lower, but did not differ significantly from children with rhinitis (7,718 and 21,612 copies of viral RNA per microliter nasal wash, respectively; P = 0.48). The odds for wheezing were increased if children who tested positive for RV were sensitized to one or more allergens (odds ratio, 3.9; P = 0.02). Similarly, neither peak nor cumulative viral loads differed significantly in washes from adults with asthma compared with those without asthma during the experimental RV challenge. CONCLUSIONS: During acute symptoms, children infected with RV enrolled for wheezing or acute rhinitis had similar viral loads in their nasal washes, as did adults with and without asthma infected with RV-16 experimentally.
RATIONALE: Most virus-induced attacks of asthma are caused by rhinoviruses (RVs). OBJECTIVES: To determine whether people with asthma are susceptible to an increased viral load during RV infection. METHODS: Seventy-four children (4-18 yr old) were enrolled; 28 with wheezing, 32 with acute rhinitis, and 14 without respiratory tract symptoms. Nasal washes were evaluated using quantitative polymerase chain reaction for RV to judge viral load along with gene sequencing to identify strains of RV. Soluble intercellular adhesion molecule-1, IFN-λ1, and eosinophil cationic protein in nasal washes, along with blood eosinophil counts and total and allergen-specific IgE in sera, were also evaluated. Similar assessments were done in 24 young adults (16 with asthma, 8 without) who participated in an experimental challenge with RV (serotype 16). MEASUREMENTS AND MAIN RESULTS: Fifty-seven percent of wheezingchildren and 56% with acute rhinitis had nasal washes testing positive for RV. The geometric mean of viral loads by quantitative polymerase chain reaction in washes from wheezingchildren was 2.8-fold lower, but did not differ significantly from children with rhinitis (7,718 and 21,612 copies of viral RNA per microliter nasal wash, respectively; P = 0.48). The odds for wheezing were increased if children who tested positive for RV were sensitized to one or more allergens (odds ratio, 3.9; P = 0.02). Similarly, neither peak nor cumulative viral loads differed significantly in washes from adults with asthma compared with those without asthma during the experimental RV challenge. CONCLUSIONS: During acute symptoms, children infected with RV enrolled for wheezing or acute rhinitis had similar viral loads in their nasal washes, as did adults with and without asthma infected with RV-16 experimentally.
Authors: N G Papadopoulos; P J Bates; P G Bardin; A Papi; S H Leir; D J Fraenkel; J Meyer; P M Lackie; G Sanderson; S T Holgate; S L Johnston Journal: J Infect Dis Date: 2000-06-05 Impact factor: 5.226
Authors: G P Rakes; E Arruda; J M Ingram; G E Hoover; J C Zambrano; F G Hayden; T A Platts-Mills; P W Heymann Journal: Am J Respir Crit Care Med Date: 1999-03 Impact factor: 21.405
Authors: Juan C Zambrano; Holliday T Carper; Gary P Rakes; James Patrie; Deborah D Murphy; Thomas A E Platts-Mills; Frederick G Hayden; Jack M Gwaltney; Tina K Hatley; Angela M Owens; Peter W Heymann Journal: J Allergy Clin Immunol Date: 2003-05 Impact factor: 10.793
Authors: William D Rawlinson; Zubair Waliuzzaman; Ian W Carter; Yvonne C Belessis; Katarnya M Gilbert; John R Morton Journal: J Infect Dis Date: 2003-03-26 Impact factor: 5.226
Authors: A L Duff; E S Pomeranz; L E Gelber; G W Price; H Farris; F G Hayden; T A Platts-Mills; P W Heymann Journal: Pediatrics Date: 1993-10 Impact factor: 7.124
Authors: John W Steinke; Charles D Crouse; Dewayne Bradley; Kathleen Hise; Kevin Lynch; Stilianos E Kountakis; Larry Borish Journal: Am J Respir Cell Mol Biol Date: 2003-08-14 Impact factor: 6.914
Authors: Jodell E Linder; David C Kraft; Yassir Mohamed; Zengqi Lu; Luke Heil; Sharon Tollefson; Benjamin R Saville; Peter F Wright; John V Williams; E Kathryn Miller Journal: J Allergy Clin Immunol Date: 2012-11-10 Impact factor: 10.793
Authors: Peter W Heymann; Holliday T Carper; Deborah D Murphy; Thomas A E Platts-Mills; James Patrie; Anne P McLaughlin; Elizabeth A Erwin; Marcus S Shaker; Martha Hellems; Jehanna Peerzada; Frederick G Hayden; Tina K Hatley; Rachel Chamberlain Journal: J Allergy Clin Immunol Date: 2004-08 Impact factor: 10.793
Authors: Lyndsey M Muehling; Peter W Heymann; Paul W Wright; Jacob D Eccles; Rachana Agrawal; Holliday T Carper; Deborah D Murphy; Lisa J Workman; Carolyn R Word; Sarah J Ratcliffe; Brian J Capaldo; Thomas A E Platts-Mills; Ronald B Turner; William W Kwok; Judith A Woodfolk Journal: J Allergy Clin Immunol Date: 2020-04-19 Impact factor: 10.793
Authors: Helen Y Chu; Janet A Englund; Bonnie Strelitz; Kirsten Lacombe; Charla Jones; Kristin Follmer; Emily K Martin; Miranda Bradford; Xuan Qin; Jane Kuypers; Eileen J Klein Journal: J Pediatric Infect Dis Soc Date: 2014-10-19 Impact factor: 3.164
Authors: Vishal Parikh; Jacqueline Scala; Riva Patel; Corinne Corbi; Dennis Lo; Yury A Bochkov; Joshua L Kennedy; Richard C Kurten; Stephen B Liggett; James E Gern; Cynthia J Koziol-White Journal: Am J Respir Cell Mol Biol Date: 2020-03 Impact factor: 6.914
Authors: Peter W Heymann; Thomas A E Platts-Mills; Judith A Woodfolk; Larry Borish; Deborah D Murphy; Holliday T Carper; Mark R Conaway; John W Steinke; Lyndsey Muehling; W Gerald Teague; Joshua L Kennedy; Anne-Marie Irani; Matthew D McGraw; Stephen V Early; Lisa M Wheatley; Amy P Adams; Ronald B Turner Journal: J Allergy Clin Immunol Date: 2020-02-01 Impact factor: 10.793
Authors: Santtu Heinonen; Tuomas Jartti; Carla Garcia; Silvia Oliva; Cynthia Smitherman; Esperanza Anguiano; Wouter A A de Steenhuijsen Piters; Tytti Vuorinen; Olli Ruuskanen; Blerta Dimo; Nicolas M Suarez; Virginia Pascual; Octavio Ramilo; Asuncion Mejias Journal: Am J Respir Crit Care Med Date: 2016-04-01 Impact factor: 21.405